Learn About Plasmacytoma
Hematology Oncology
University of Texas System
Physicians Referral Service
Robert Orlowski is an Oncologist and a Hematologist Oncology expert in Houston, Texas. Orlowski has been practicing medicine for over 32 years and is rated as an Elite expert by MediFind in the treatment of Plasmacytoma. He is also highly rated in 16 other conditions, according to our data. His top areas of expertise are Multiple Myeloma, Plasmacytoma, Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Orlowski is currently accepting new patients.
Hospital Clínic De Barcelona
Joan Blade practices in Barcelona, Spain. Blade is rated as an Elite expert by MediFind in the treatment of Plasmacytoma. She is also highly rated in 8 other conditions, according to our data. Her top areas of expertise are Plasmacytoma, Multiple Myeloma, Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Institut Curie
Youlia Kirova practices in Paris, France. Kirova is rated as an Elite expert by MediFind in the treatment of Plasmacytoma. They are also highly rated in 13 other conditions, according to our data. Their top areas of expertise are Plasmacytoma, Breast Cancer, Mediastinal Tumor, Mastectomy, and Bone Marrow Aspiration.
Summary: This phase IV trial studies how well influenza vaccination works in preventing infections such as influenza in patients with plasma cell disorders. Influenza infections may theoretically support the growth of tumor cells and improving protection against influenza may improve the status of patients' plasma cell disorder. Giving influenza vaccination may reduce influenza-related complications includ...
Summary: This phase I trial studies the side effects and best dose of MDM2 Inhibitor KRT-232 when given together with carfilzomib, lenalidomide, and dexamethasone in treating patient with multiple myeloma that has come back (relapsed) or has not responded to previous treatment (refractory). KRT-232 (AMG 232) may stop the growth of cancer cells by blocking a protein called MDM2 that is needed for cell growt...
Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center